Please login to the form below

Not currently logged in
Email:
Password:

Prescient names vice president global head of advisory

Dr Debasish Talukdar joins the consultancy from Bain & Company

Debasish TalukdarPrescient Healthcare Group, a biopharmaceutical product strategy and decision support consultancy, has named Dr Debasish Talukdar as its new vice president, global head of advisory.

His new role will see him take responsibility for the future trajectory for the group’s advisory practice.

Talukdar said: “I’m very excited to have joined Prescient and see huge opportunity to grow VantageRX, our advisory services business.

“We have an incredible team that offers a differentiated level of service to our clients through in-depth technical, therapeutic and market expertise.”

He joins the group from Bain & Company, where he was a leader in the healthcare practice gaining expertise in advising biopharma clients on value creation through corporate, business unit, disease area and product-focused strategies.

Jamie Denison-Pender, chief executive officer of Prescient, said: “His [Talukdar] tier 1 consultancy experience coupled with his medical background makes him a fantastic fit for us.

“Debasish has a real passion for problem solving and is an expert at understanding the nuances associated with a client need and then framing an optimal solution.”

27th February 2018

From: Marketing

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
COUCH Health

We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...

Latest intelligence

EU health fund
An EU emergency health fund to limit the impact of future crises
Leading finance experts propose an Emergency Health Financing Facility to limit the impact of future crises on the EU...
Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...

Infographics